Bladder Cancer VL

Financial Toxicity Among Patients with Bladder Cancer - Deborah Kaye

Details
Urologic Oncologist, Deborah Kaye joins Ashish Kamat in a conversation on financial toxicity among bladder cancer patients highlighting the costs of bladder cancer, what is financial toxicity, and lastly, some of the research done on financial toxicity in bladder cancer. Biographies: Deborah Kaye, MD, MS, Urologic Oncologist, Assistant Professor of Surgery, Division of Urology, Duke Cancer Center,...

Bladder Cancer: A Practical Guide - Ashish Kamat & Peter Black

Details
Alicia Morgans is joined by Ashish Kamat and Peter Black to discuss their recent book on bladder cancer, Bladder Cancer: A Practical Guide. This book provides a practical, comprehensive, state-of-the-art review of bladder cancer, and is a valuable resource for anyone with an interest in urothelial tumors. Biographies: Peter Black, MD, Senior Research Scientist, Vancouver Prostate Centre, Professor...

Urologists, You’ll Never Walk Alone! - Gianluca Giannarini

Details
Gianluca Giannarini joins Ashish Kamat to discuss a recent publication from European Urology Oncology, an editorial titled, "Urologists, You’ll Never Walk Alone! How Novel Immunotherapy and Modern Imaging May Change the Management of Non–muscle-invasive Bladder Cancer". Dr. Giannarini discusses the management of patients with high-risk non–muscle-invasive bladder cancer (NMIBC), especially those w...

Systemic Therapies in Advanced Bladder Cancer - Noah Hahn

Details
In this 2021 LUGPA MCE presentation, Noah Hahn presents Systemic Therapies in Advanced Bladder Cancer. He reviews the current data and experiences with immune checkpoint inhibitor therapies, (ICI) targeted therapies, and antibody-drug conjugate (ADC) therapies. Biographies: Noah M. Hahn, MD, Professor of Oncology and Urology, Department of Oncology and Urology, Johns Hopkins University School of M...

Management of Small Local Recurrence Low-grade Bladder Tumors with Negative Cytology - Marek Babjuk, Morgan Roupret & Wassim Kassouf

Details
Ashish Kamat is joined by Marek Babjuk, Morgan Roupret, and Wassim Kassouf for a rapid-fire debate on the management of small local recurrence low-grade bladder tumors with negative cytology. The patient in this debate is an 81-year-old male with multiple medical comorbidities. Dr. Morgan Roupret argues for formal TURBT with intravesical chemotherapy while Dr. Wassim Kassouf argues for active surv...

The World Bladder Cancer Patient Coalition Launches Bladder Cancer Patient Survey

Details
Lydia Makaroff, Stephanie Chisolm, and Alex Filicevas join Ashish Kamat on UroToday's Bladder Cancer Center of Excellence for a round table discussion on the importance of bladder cancer from a patient perspective and recent efforts by The World Bladder Cancer Patient Coalition. Their recently launched evidence generation study, or bladder cancer patient survey, aims to capture bladder cancer pati...

Financial Toxicity in Bladder Cancer—A Mixed Methods Study of Two Diverse Patient Populations - Sumeet Bhanvadia

Details
Ashish Kamat and Sumeet Bhanvadia, discuss the burden and impact of financial toxicity amongst a diverse population in bladder cancer patients. This conversation kicks off with a background on financial toxicity and how it may affect patient outcomes. Dr. Bhanvadia goes on to discuss the social and clinical determinants of financial toxicity among a diverse sample of bladder cancer patients. Dr. B...

The Association of Smoking Status with Recurrence in Patients with Predominantly High-Risk Recurrent NMIBC - Richard Matulewicz

Details
Richard Matulewicz joins Ashish Kamat presenting findings on the association of smoking status on recurrence of non-muscle invasive bladder cancer (NMIBC) in a contemporary cohort of patients with predominantly high-risk, recurrent NMIBC managed with photodynamic enhanced cystoscopy. A retrospective study was conducted in a multi-institutional registry. Smoking has a strong causal association with...

Value Based Care in Surveillance of Non-Muscle Invasive Bladder Cancer – Stephen Williams

Details
Stephen Williams joins Ashish Kamat presenting findings on macro and microeconomics of blue light cystoscopy (BLC) with CYSVIEW® in the care of patients with non-muscle invasive bladder cancer, a Urologic Oncology Seminars and Original Investigations publication. The aim of the study was to determine the estimated budget impact to practices that incorporate blue light cystoscopy with hexaminolevul...

ctDNA Guiding Adjuvant Immunotherapy in Urothelial Carcinoma Journal Club – Christopher Wallis & Zachary Klaassen

Details
Christopher Wallis and Zachary Klaassen discuss a recently published paper, entitled, “ctDNA Guiding Adjuvant Immunotherapy in Urothelial Carcinoma.” They discuss the basics of circulating tumor DNA (ctDNA). He specifically discusses how we can use ctDNA to identify molecularly, or microscopic, residual disease. The study shows that ctDNA-positive patients with adjuvant atezolizumab, after surgery...
email news signup